Calimmune - Ownership and Business Overview

Life ScienceCompany

Calimmune Ownership

Who owns Calimmune?

Calimmune is owned by CSL Behring. It was acquired on August 28, 2017.

Calimmune Business Overview

Where is Calimmune headquartered?

Calimmune is headquartered in Tuscon, Arizona.

What sector is Calimmune in?

Calimmune is a life science company.

When was Calimmune founded?

Calimmune was founded in 2000.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Subscribe to Mergr to view all 252 acquisitions of life science companies in 2017, including 24 acquisitions by private equity firms, and 228 by strategics.

Calimmune, Inc.

5151 East Broadway Boulevard,
Tuscon, Arizona 85711
United States,
(520) 514-8000
www.calimmune.com

Calimmune, Inc. is a biotechnology company focused on the development of ex vivo hematopoietic stem cell (HSC) gene therapy. Calimmune, Inc. was founded in 2000 and is based in Tuscon, Arizona.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Calimmune

Life Science Companies